How is it used?
A test for quantitative immunoglobulins (Igs) is used to detect an excess or deficiency in the three major classes of immunoglobulins (IgG, IgA, and IgM). It gives important information about the health of an individual's immune system and is used to help diagnose various conditions and diseases that affect the levels of one or more of these Ig classes.
Immunoglobulins, also called antibodies, are proteins produced by plasma cells. They target specific "threats" and play a key role in the body's immune system. Immunoglobulins are produced in response to exposure to bacteria, viruses, and other microorganisms as well as other substances that are recognized by the body as "non-self" harmful antigens.
In general, immunoglobulin disorders can be classified as:
- Immunoglobulin excess
- Polyclonal: Excess is the sum of immunoglobulins from many different immune (plasma) cells
- Monoclonal: Excess immunoglobulins are from the clones of one plasma cell
- Immunoglobulin deficiency
- Secondary (acquired)—the most common are caused by an underlying condition or contributing factor
- Primary (inherited)—rare disorders in which the body is not able to produce one or more classes of immunoglobulins
This test may be ordered along with others, such as a serum and/or urine protein electrophoresis, to help diagnose and monitor conditions associated with abnormal or excessive immunoglobulin production. When this is the case, a urine sample may be collected in addition to blood.
If an excessive amount of one of the immunoglobulin types is present, further testing by immunofixation can be done to determine if the immunoglobulin comes from clones of an abnormal plasma cell (monoclonal gammopathy). M are seen with multiple myeloma, a malignancy of plasma cells. Serum free light chain testing may also be performed.
When is it ordered?
This test is ordered when a person has symptoms of an immunoglobulin deficiency such as recurrent infections, especially of the respiratory tract (sinus, lungs) or gastrointestinal tract (stomach, intestines), and/or chronic diarrhea.
Immunoglobulins testing may also be ordered when a person has signs of chronic inflammation or chronic infection and when a health practitioner suspects excess or abnormal immunoglobulin production.The test may be ordered periodically to monitor the course of a person's condition.
This test may also be performed on cerebrospinal fluid (CSF) whenever a health practitioner suspects that a condition affecting the central nervous system may be associated with excess immunoglobulin production.
What does the test result mean?
The results of the tests for IgG, IgA, and IgM levels are usually evaluated together.Abnormal test results typically indicate that there is something affecting the immune system and suggest the need for further testing. Quantitative immunoglobulins testing is not diagnostic but can be a strong indicator of a disease or condition. There are a number of conditions that are associated with increased and decreased immunoglobulins.
High levels
Increased polyclonal immunoglobulins may be seen with a variety of conditions. Monoclonal immunoglobulins are seen in blood cell tumors that involve lymphocytes or plasma cells. In these disorders, there is typically a marked increase in one class of immunoglobulin and a decrease in the other two classes.Although affected people may have an increase in total immunoglobulins, they are actually immunocompromised because most of the immunolglobulins produced are abnormal and do not contribute to the immune response.
The following table lists some examples of conditions that may cause increased immunoglobulins:
Immunoglobulin Result |
Associated Conditions |
Polyclonal increase in any or all of the three classes (IgG, IgA and/or IgM) |
- Infections, acute and chronic
- Autoimmune disorders (rheumatoid arthritis, systemic lupus erythematosus, scleroderma)
- Cirrhosis
- Chronic inflammation, inflammatory disorders
- Hyperimmunization reactions
- Wiskott-Aldrich syndrome
- In a newborn, infection during pregnancy (congenital—syphilis, toxoplasmosis, rubella, CMV)
|
Monoclonal increase in one class with or without decrease in other two classes |
- Multiple myeloma
- Chronic lymphocytic leukemia (CLL)
- MGUS(monoclonal gammopathy of undetermined significance)
- Lymphoma
- Waldenstrom's macroglobulinemia (IgM)
|
Low levels
The most common causes of decreased immunoglobulins are acquired underlying (secondary) conditions that either affect the body's ability to produce immunoglobulins or that increase the loss of protein from the body. Deficiencies may also be due to drugs such as immunosuppressants, corticosteroids, phenytoin, and carbamazepine or due to toxins.
The table below lists some of the common causes of low levels:
Conditions/factors that affect immunoglobulin production |
- Drugs such as phenytoin, carbamazepine, immunosuppressant drugs
- Complications from conditions such as kidney failure or diabetes
- Transient delay in production in newborns, particularly premature infants
|
Conditions that cause an abnormal loss of protein |
- Nephrotic syndrome—kidney disease in which protein is lost in the urine
- Burns
- Protein-losing enteropathy—any condition of the gastrointestinal tract that affects the digestion or absorption of protein
|
Inherited immune deficiencies are rare and are often referred to as primary immunodeficiencies. (For more on this, see the links on the Related Pages tab). They may affect the production of all immunoglobulins, a single class, or one or more subclasses. Some of these disorders include agammaglobulinemia, common variable immunodeficiency (CVID), x-linked agammaglobulinemia, ataxia telangiectasia, Wiskott-Aldrich syndrome, hyper-IgM syndrome, and severe combined immunodeficiency (SCID).
In CSF, immunoglobulins normally are present in very low concentrations.Increases may be seen, for example, with central nervous system infections (meningitis, encephalitis), inflammatory conditions, and multiple sclerosis.
Decreases in salivary IgA may be seen in those with recurrent respiratory infections.
Is there anything else I should know?
Sometimes an IgM test is used to determine whether a newborn acquired an infection before birth (congenital). IgM may be produced by a developing baby (fetus) in response to infection. Due to the size of IgM antibodies, they cannot pass through the placenta from mother to baby during pregnancy. Thus, any IgM antibodies present in a newborn's blood are not from the mother but were produced by the baby. This indicates that an infection began during pregnancy.
Infants with otherwise normal immune systems may have temporarily decreased IgG levels when production is delayed. Protection from infections is lost as concentrations of the mother's IgG in the baby's blood decrease over several months. The level of IgG remains at low concentrations until the baby's IgM and IgG production ramps up. This creates a period of time during which the baby is at an increased risk for recurrent infections.
Infants who are breastfed acquire IgA from breast milk. The IgA in breast milk can be protective against infections, particularly in the time between the decrease of mother's antibodies and the production of the baby's own antibodies.
Those with conditions that cause decreased immunoglobulin levels often do not have a strong immune response to vaccinations; they may not produce a sufficient level of antibody to ensure protection and may not be able to receive live vaccines, such as those for polio or measles.
Many laboratory tests measure antibodies in the blood. Those with immunoglobulin deficiencies may have false-negative results on these types of tests. For example, one test for celiac disease detects the IgA class of anti-tissue transglutaminase antibody (anti-tTG). If a person has a deficiency in IgA, then results of this test may be negative when the person, in fact, has celiac disease. If this is suspected to be the case, then a quantitative test for IgA may be performed.
If IgG or IgA concentrations are decreased, or a deficiency in one of their subclasses is suspected, then subclass testing may be performed to detect and further define the deficiency. Subclass deficiencies can be present even when an immunoglobulin class concentration, such as IgG, is normal.
Some people with IgA deficiencies may develop anti-IgA antibodies. When those with anti-IgA are given blood component transfusions that contain IgA (such as plasma or immunoglobulin treatments), they may experience a severe anaphylactic transfusion reaction.